Article
Methylenetetrahydrofolate reductase: biochemical characterization and medical significance.
Current pharmaceutical design - 1 Jan 2013
Trimmer Elizabeth E
Abstract excerpt
Methylenetetrahydrofolate reductase (MTHFR) catalyzes the reduction of 5,10-methylenetetrahydofolate (CH2-H4folate) to 5-methyltetrahydrofolate (CH3-H4folate). The enzyme employs a noncovalently-bound flavin adenine dinucleotide (FAD), which accepts reducing equivalents from NAD(P)H and transfers them to CH2-H4folate. The reaction provides the sole source of CH3-H4folate, which is utilized by methionine synthase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
